Open original FDA record ↗Recall record
- FDA identifier
- Z-1936-2019
- Company in FDA record
- Ortho-Clinical Diagnostics
- FDA record creation date
- Jul 3, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Potential negative drift in Creatine Kinase (CK) results when used on the VITROS 250 and 350 Systems.
Source facts
- Action
- On 08 April 2019, a customer letter (Ref. CL2019-090) was sent via FedEx overnight courier and/ or ORTHO PLUS e-Communications and and/or US Postal Service Priority Mail (for PO Boxes only) to either all customers who were shipped affected VITROS 250 or 350 Systems. This communication provided the following required actions: - As per the VITROS CK Slide Instructions for Use, perform Quality Control (QC) testing daily to help ensure the slides are performing within acceptable limits. - If QC results are outside of the established ranges, discard the cartridge and repeat QC testing using a fresh cartridge of VITROS CK Slides. - If multiple cartridges are loaded on the VITROS 250/350 System, daily QC testing must be performed for each cartridge prior to use. - Consider loading one cartridge of VITROS CK Slides on board your system at a time. - Complete and return the request form via fax to 1-888-557-3759. Foreign affiliates were informed by email on 08 April 2019 of the issue and instructed to notify affected consignees of the issue and appropriate actions to take.
- Initiated
- 2019-04-08
- Root cause
- Device Design
- Terminated
- 2020-11-12
- Distribution
- US Nationwide Distribution
- Recall number
- Z-1936-2019
- Recall status
- Terminated
- CDRH record ID
- 172700
- FDA record created
- 2019-07-03
- Recall event number
- 82784